Development of Promising CDK5 Inhibitors Using Structure‐Based Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Approach

Documenti analoghi

• Structure‐Based Computational Approach in Search of the Potent Molecules Targeting Phosphoglycerate Dehydrogenase (PHGDH) Enzyme for Cancer Treatment
  di: Priyanka Solanki, et al.
  Pubblicazione: (2024)
• Structure‐Based Approaches for the Prediction of Alzheimer's Disease Inhibitors: Comparative Interactions Analysis, Pharmacophore Modeling and Molecular Dynamics Simulations
  di: Enfale Zerroug, et al.
  Pubblicazione: (2024)
• Design and Evaluation of 2,5‐Diketopiperazine EGFR Inhibitors Using Molecular Docking and Dynamics Simulations
  di: Yudhi Dwi Kurniawan, et al.
  Pubblicazione: (2025)
• Integration of Consensus‐Based Pharmacophore Mapping and Molecular Docking in Sequential Virtual Screening: Toward the Discovery of Novel PI3Kγ Inhibitors
  di: Xiaolian Yu, et al.
  Pubblicazione: (2024)
• Structure‐Guided In Silico Design of CK1α Inhibitors Using Pharmacophore Modeling, De Novo Design, Molecular Dynamics Simulations, and DFT Calculations
  di: Rahma Abrane, et al.
  Pubblicazione: (2026)